Zsírmáj (MASLD/MASH): vizsgálatok itt: Norvégia
2 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Where
- Oslo, Tromsø
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00 - No phaseNot yet taking people in NorvégiaDetecting Liver Fibrosis in Patients At-risk
- Where
- Stavanger
- Életkor
- 40 év to 70 év
- People
- 1200
- Run by
- Helse Stavanger HF
See details and how to joinNCT07775638